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Edited by Sandro SonninoAbstract Defects of cell–cell adhesion underlie disruption of
epithelial integrity observed in patients with pemphigus vulgaris
(PV), an autoimmune disease characterized by severe mucosal
erosions and skin blisters. Pathogenic PV autoantibodies found
in patients’ sera target desmoglein 3 (Dsg3), a major component
of the desmosome, but how does this phenomenon aﬀect Dsg-
dependent adhesion and lead to acantholysis still remains contro-
versial. Here, we show that PV serum determines a reduction of
Dsg3 half-life in HaCaT keratinocytes, although the total
amount of Dsg3 remains unchanged. Immunoﬂuorescence studies
suggest that PV IgG exert their eﬀect prevalently by binding
non-desmosomal Dsg3 without causing its massive internaliza-
tion. Furthermore, PV IgG targeting desmosome-assembled
Dsg3 do not induce depletion of Dsg3 from the adhesion sites.
Conversely, incorporation of PV IgG-Dsg3 complexes into new
forming desmosomes appears perturbed. With our study, the ba-
sic biochemical changes of Dsg3 in an in vitro model of PV have
been deﬁned.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Desmoglein 3 (Dsg3) is the best characterized autoantigen of
pemphigus vulgaris (PV), an autoimmune disease targeting
keratinocyte adhesion [1]. Dsg3 is found in the basal and spi-
nous layers of the epidermis and gradually diminishes as the
cells became more diﬀerentiated, whereas in the oral mucosa
Dsg3 is detected at high levels in all cell layers [2]. Although
PV autoantibodies have been shown to cause the clinical and
histologic lesions of pemphigus, the speciﬁc pathophysiological
mechanisms by which they do so are not fully understood (for
review, see [3]). Desmoglein compensation theory has sug-
gested that PV IgG can cause direct inhibition of desmogleins’
adhesive function through steric hindrance [4]. Alternatively,
Dsg3 can act as a receptor by triggering complex intracellular
events, including changes in intracellular calcium concentra-
tion, PKC and p38 MAPK activation, apoptosis, transcrip-*Corresponding author. Fax: +39 0815665477.
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desmosome disassembly [5–10]. Furthermore, binding of auto-
antibodies to Dsg3 could modulate its own synthesis, leading
to the formation of aberrant desmosomes lacking Dsg3 both
in vitro [11] and in vivo [12]. However, biochemical studies fo-
cused on Dsg3 turn-over in normal and pathologic conditions
are still lacking.
To date, it is not yet clear whether PV IgG are able to bind
desmosome-assembled Dsg3 or block its extracellular domain
before Dsg3 engages contacts with apposed cells and, however,
it remains to address whether these interactions can cause des-
mosome splitting or prevent formation of new desmosomes,
respectively. With regard to this, it is worth of note that
detachment of keratinocytes from each other seems to occur
ﬁrst in the interdesmosomal areas, while desmosomes appear
to separate only in the late acantholysis [13].
Cell–cell dissociation by calcium depletion has been demon-
strated in several cell types, including primary keratinocytes
and various cell lines derived from stratiﬁed epithelia, such
as HaCaT [14,15]. In low calcium conditions, desmosomes
are unstable and desmogleins rapidly become internalized after
reaching the surface [15–17] with subsequent accumulation of
cytoplasmic vesicles. Similar structures are endocytotically
formed after the disruption of desmosomes by proteases (Lan-
za and Cirillo, unpublished data; [18]) and PV IgG [19,20], sug-
gesting that Dsg3 cross-linking could become unstable after
binding to PV autoantibodies.
In the present study, we sought to determine whether auto-
antibodies from PV sera (a) induce alterations of Dsg3 turn-
over, (b) deplete Dsg3 from assembled desmosomes or cause
their splitting and/or (c) prevent the recruitment of PV IgG-
bound Dsg3 into desmosomes. For our purpose, we have eval-
uated these changes in terms of half-life and dynamic of Dsg3
assembly at sites of cell–cell contact by exposing HaCaT kerat-
inocytes to PV serum.2. Materials and methods
2.1. Antibodies and reagents
The 5H10 mouse monoclonal antibody against the extracellular do-
main of Dsg3, anti-Dsg3 H-145 rabbit polyclonal antibodies raised
against the cytoplasmic domain of Dsg3, H-290 rabbit antibodies
against C-terminal residues 760–1046 of Dsg1, anti-pancytokeratin
rabbit IgG and HRP-conjugated anti-rabbit and anti-mouse antibod-
ies were from Santa Cruz Biotecnology (Santa Cruz, CA). Texas
Red- or FITC-conjugated anti-human, anti-mouse and anti-rabbitblished by Elsevier B.V. All rights reserved.
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lose ﬁlters were purchased from Invitrogen (Carlsbad, CA); ECL
chemiluminescent immunodetection system and Hyperﬁlms were from
Amersham (Buckinghamshire, UK). Cycloheximide (CX), protease
inhibitors and cell culture reagents were from Sigma (St. Louis,
MO), except keratinocyte growth medium (KGM), purchased from
Gibco BRL (Gaithersburg, MD).
2.2. PV patients and healthy donors
Serum samples were collected from three patients with mucosal PV
and three healthy donors. The diagnosis of PV was made based on the
results of both clinical and histological examinations and direct immu-
noﬂuorescence (DIF). In pemphigus patients, the presence of autoan-
tibodies was determined by indirect immunoﬂuorescence using monkey
oesophagus as substrate (values above 1:80 of circulating anti-ICS
antibodies were considered as positive) and by enzyme-linked immuno-
sorbent assay (ELISA) against Dsg1 and Dsg3. Mucosal PV patients
selected for this study did not show detectable titres of anti-Dsg1 anti-
bodies at the time of serum collection. All sera were heated to 56 C for
30 min to inactivate complement. Figures shown in the present paper
were obtained using PV1 and control 1 sera. Results were conﬁrmed
in independent experiments with PV2–3 and control 2–3 sera.2.3. Cell cultures and treatments
For our experiments, we used HaCaT cells, a non-tumorigenic hu-
man keratinocyte cell line which exhibits normal diﬀerentiation and
is capable to form epidermal tissue when transplanted in vivo [21].
Cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 10% FBS, penicillin (50 U/ml), strepto-
mycin (50 lg/ml) and fungizone (2.5 lg/ml) in an atmosphere umidiﬁed
with 5% CO2. At the time of the experiment, cells were seeded and
grown to conﬂuence for 4 days on 35 mm Petri dishes. Eventually, cells
were transferred to low calcium medium (Ca < 0.1 mM) supplemented
with growth factors (KGM), according to the manufacturer’s instruc-
tions.
Because IgG and complement-inactivated sera exert the same eﬀects
on cultured keratinocytes (our personal observation and those from
[11,20]), experiments were carried out with 25% sera from PV patients
and controls. For the analysis of desmoglein 3 half-life, cells were trea-
ted with 50 lg/ml CX to block protein synthesis and harvested at dif-
ferent time points.2.4. Protein extraction and Western blot analysis
Cells were grown to conﬂuence on 35 mm Petri dishes, rinsed with
complete PBS and scraped in PBS supplemented with protease inhibi-
tors (phenylmethylsulfonylﬂuoride (PMSF) at 1 mM, 10 lg/ml leupep-
tin and 5 lg/ml aprotinin). Pellets (800 · g for 10 min) with equivalent
cell numbers (5 · 105) were resuspended in Laemmli sample buﬀer [22]
and loaded onto an 8% SDS–PAGE after heating for 5 min at 95 C.
Proteins were transferred overnight onto nitrocellulose membranes at
20 V. Blocked membranes were incubated for 1 h with H-145 rabbit
polyclonal antibodies (1:1000) and then with anti-rabbit HRP-conju-
gated IgG (1:10000) as secondary antibody. Bound antibodies were de-
tected by ECL chemiluminescent immunodetection system. To
ascertain that blots were loaded with equal amounts of protein lysates,
ﬁlters were also incubated with a polyclonal antibody against b-actin
protein. Band intensity was quantiﬁed by scanning ﬁlms with the
Molecular Analysis Software (Bio-Rad, Richmond, CA).2.5. Immunoprecipitation
Pelleted cells from a 35 mm wells were suspended in immunoprecip-
itation buﬀer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.5% Nonidet
P-40, 1 mM DTT, 1 mM PMSF) and centrifuged for 30 min at
16000 · g; 300 ll supernatants were incubated for 1 h with PV serum
1:1, 20 ll anti-Dsg3 H-145 polyclonal antibodies or H-290 antibodies
against Dsg1, after which 15 ll protein A–Sepharose were added for
2 h. After centrifugation at 2300 · g for 10 min, beads containing anti-
gen-antibody complexes were washed as described elsewhere to in-
crease the eﬃciency of immunoprecipitation [15] and Western
blotting was performed as detailed above. For the immunoreactivity
assay, IgG from 300 ll of PV serum were ﬁrst precipitated with protein
A–Sepharose at 16000 · g and PV IgG-depleted serum was discarded.
Proteins were extracted using low calcium immunoprecipitation (LCI)buﬀer (10 mM Tris–HCl, 5 mM EDTA, 0.5% Nonidet P-40, 1 mM
DTT, and 1 mM PMSF); then 600 ll supernatant was added to PV-
IgG or 40 ll 5H10 anti-Dsg3 IgG for 2 h and immunoprecipitation
was continued as described above.
2.6. Immunoﬂuorescence microscopy
Cells were grown on glass coverslips and incubated in the presence
or absence of normal or PV complement-inactivated sera and CX.
After washing with PBS, cells were ﬁxed and permeabilized in parafor-
maldehyde solution (3% paraformaldehyde in PBS containing 0.1%
Triton X-100) for 20 min at room temperature. Samples were then
washed three times in PBS containing 2% BSA to block non-speciﬁc
sites, incubated with primary antibody (1:10) for 1 h at room temper-
ature, washed in BSA/PBS, and exposed to specie-speciﬁc antibodies
(1:100) conjugated to FITC or Texas Red. If necessary, ﬁxed cells were
directly incubated with FITC-conjugated anti-human IgG as second-
ary antibody. Specimens were examined with a Zeiss Axiophot micro-
scope (Calr Zeiss Inc., Thornwood, NY) at 1000· magniﬁcation and
ﬂuorescence images were acquired with an Evolution VF fast digital
camera (MediaCybernetics, UK).3. Results
3.1. Characterization of sera from PV patients and check of the
PV in vitro model
Sera from three patients with well characterized mucosal PV
(Fig. 1A) and three healthy volunteers were used for this study.
Immunoﬂuorescence on HaCaT keratinocytes showed that PV
IgG, but not Nh IgG, described the ﬁshnet-like pattern typical
of PV (Fig. 1B and C), indicating that in our experimental cell
system PV IgG targeted antigen(s) located in the intercellular
substance (ICS). Immunoreactivity of PV IgG was further
identiﬁed by immunoprecipitation of HaCaT extracts with
PV sera. Western blot analysis of the immunocomplexes re-
vealed that PV IgG recognized Dsg3 but not Dsg1 (Fig. 1D),
as already determined by ELISA (see Section 2).
At the time of the experiment, cultured monolayers ex-
pressed Dsg3 and low rates of Dsg1 (assessed by WB,
Fig. 1D, lane 1 (Positive controls); and RT-PCR, not shown).
This in vitro pattern of expression resembles that observed
in vivo in the spinous layer of mucous membranes [4]. Indeed,
at the selected stage of diﬀerentiation, HaCaT cells synthesized
high levels of Dsg3 and were useful for our purposes. Although
it is accepted that IgG and complement-inactivated sera exert
the same eﬀects on keratinocytes [11,20], we tested the ability
of whole PV sera to induce acantholysis in our experimental
conditions. Immunoﬂuorescence performed on cultured Ha-
CaT revealed that incubation with 25% PV serum induced spe-
ciﬁc changes in cytoskeleton organization, such as retraction of
keratin ﬁlaments from cell borders (Fig. 1E and F), which is
considered an hallmark of pemphigus acantholysis [9].
3.2. Pemphigus serum induces reduction of Dsg3 half-life
To appreciate changes in Dsg3 half-life after exposure to PV
and normal sera, we ﬁrst assessed half-life of Dsg3 in keratino-
cytes cultured in normal conditions (DMEM + 10% FBS).
Thus, cells were treated with 50 lg/ml CX and harvested at dif-
ferent time points afterward for the preparation of cell lysates.
Dsg3 from cells grown in normal conditions showed a t1/2 of
about 24 h (Fig. 2A and B, CX), similar to that observed in
HaCaT exposed to normal serum (not shown). When serum
from PV patients was added together with CX, no relevant
changes in Dsg3 half-life (t1/2  23 h) were revealed compared
with controls, although after 24 h the absolute amount
Fig. 1. Characterization of sera. (A) The skin blister in PV1 resulted from a typical lower acantholysis observed by hematoxylin and eosin
examination of the perilesional skin. PV1-IgG (B), but not normal human (Nh) C1-IgG (C), immunostained antigen(s) located in the intercellular
substance (ICS) of HaCaT keratinocytes. Autoantibodies from PV1 recognized Dsg3 but not Dsg1 (D). 25% (v/v) serum from PV1 (E), but not
normal serum from C1 (F), induce collapse of keratin ﬁlament in cultured HaCaT. Equal observations were made with PV2–3 and C2–3. PV, patient
with pemphigus vulgaris; C, healthy volunteer (control).
Fig. 2. Treatments with sera and/or CX were conducted as described in the text. The level of Dsg3 was analyzed by using Western blot (A),
quantiﬁed and normalized by measuring the density of Dsg3 and b-actin signals, and plotted using Microsoft Excel (B). Formulas for calculating t1/2
are: YCX = 0.0181X + 0.865; YCX+PV = 0.0186X + 0.844; YprePV+CX = 0.0183X + 0.6675. Straight lines were realized by considering the main
values of three independent experiments. (C) Dsg3 level by Western blot and immunoﬂuorescence of HaCaT cells within 36 h of treatment with 25%
PV serum. Experiments shown in this ﬁgure were conducted using PV1 and C1 sera. Comparable results were obtained with PV2–3 and C2–3.
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starting values (Fig. 2A and B, CX + PV). However, pretreat-
ment with PV serum 12 h before the addition of CX deter-
mined a reduction of Dsg3 half-life to 18 h (Fig. 2A and B,
prePV + CX), while cells pretreated with normal serum keep
values of about 24 h (not shown). To exclude that changes ob-
served by pretreating cells were related to a longer exposure to
PV serum, we investigated the total amount of Dsg3 in re-
sponse to sera along a 36 h period. Western blot and immuno-ﬂuorescence analyses revealed that PV sera did not cause
changes in the cellular amount of Dsg3 within 36 h, although
cells became to round up (Fig. 2C). Thus, we considered the
reduction of Dsg3 half-life as an eﬀect of treating cells with
PV sera before the addition of CX. It is reasonable that this
ﬁnding was related to the ability of PV autoantibodies to bind
newly synthesized Dsg3 that reached cell surface in the ﬁrst
12 h (i.e. before stopping protein synthesis) and had not yet
established transinteraction.
Fig. 4. (A and B) The double-staining showed that FITC-positive (PV-
IgG) sites also were stained with Texas Red (Dsg3); both PV-IgG and
monoclonal 5H10 antibody were able to recognize (A and C) and
immunoprecipitate (D) Dsg3 in low calcium conditions. PV-IgG were
still labelled on keratinocytes’ surface 9 (E) and 18 (F) hours after
removing serum and switching cells to 0.9 mM Ca++. Figure is
representative of independent experiments conducted with PV1–3 and
C1–3 sera.
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desmosomes
To address whether serum PV IgG are able to dismantle des-
mosomal complexes, we stopped protein synthesis with CX to
prevent formation of new desmosomes and then incubated
cells with 25% PV sera. Immunoﬂuorescence analysis showed
PV IgG at sites of cell–cell contact, identiﬁed as punctate stain-
ing between adjacent cells, 24 h after treatment (Fig. 3A and
B). This ﬁnding suggests that PV autoantibodies are not able
to disrupt desmosomal adhesion when stable contacts are
done. Preincubation (12 h) with PV serum, however, deter-
mined a decrease of PV IgG staining at desmosomal areas; in-
deed, ﬂuorescence was revealed as a linear pattern all around
cell borders (Fig. 3A and C). Thus, pemphigus serum is likely
to perturb the stability of desmosomes by binding non-clus-
tered Dsg3 before they have established interconnections with
adjacent cells. Conversely, PV IgG do not deplete Dsg3 from
adhesion sites nor disrupt preexisting desmosomes through di-
rect interferences.
3.4. PV IgG-bound Dsg3 is not early internalized but does not
form desmosomes
To understand whether Dsg3, when bound to PV IgG, is re-
cruited to the sites of cell–cell contact to become assembled
into desmosomes, we cultured keratinocytes in low calcium
medium (Ca2+ < 0.1 mM). These culture conditions lead to a
rapid loss of desmosomal adhesion by splitting such structures
into desmosomal halves. Although a loss of Dsg3 antigenicity
after calcium depletion has been reported [23], we found that
in our low calcium cell system PV IgG co-localize with, and
are able to immunoprecipitate, Dsg3 (Fig. 4A–D). Thus, the
desmosome-deﬁcient cells were exposed for 1 h to 25% PV or
normal serum, then media were changed and cultures switched
to high calcium conditions to allow formation of stable desmo-
somes. As shown by immunoﬂuorescence experiments, PV IgG
localized at cell borders, suggesting that PV IgG-Dsg3 com-
plexes were not markedly internalized within 18 h after binding
to PV autoantibodies (Fig. 4E and F).
To further investigate the eﬀect of PV serum on cells forming
de novo desmosomes, we trypsinized cells and, after removal
of trypsin, plated them in presence of PV serum (25% ﬁnal con-
centration). Within 12 h, cells became to aggregate and estab-
lish transinteraction, as revealed by an intense punctate
staining of Dsg1 at sites of cell–cell contact (Fig. 5C). How-
ever, Dsg3 and PV IgG did not markedly enter the desmo-
somal pool, since both co-localized in a linear pattern
(Fig. 5A and B). After 36 h, desmosomes were no longer la-Fig. 3. Immunoﬂuorescence showing PV-IgG distributon on keratinocytes’ su
contact areas. (C) In cells treated with PV serum 24 h before the addition of C
Figure is representative of independent experiments carried out with PV1-3belled on cell surface through Dsg1 and Dsg3 staining, sug-
gesting that cell–cell contacts had been disrupted. Taken
together, our data demonstrate that PV IgG do not cause a ra-
pid disappearance of Dsg3 from cell surface but, when bound
to non-desmosomal Dsg3, PV IgG prevent a stable assembly
of Dsg3 into adhesion areas.4. Discussion
In the present study, we demonstrate that an eﬀect of PV ser-
um is the reduction of Dsg3 half-life in keratinocytes. This
ﬁnding could be related to the ability of PV autoantibodies
to interfere with the stability of non-desmosomal Dsg3 butrface. (A and B) FITC is localized in a punctate pattern within cell–cell
X, PV-IgG described a diﬀuse, linear outline on the entire cell surface.
and C1-3 sera.
Fig. 5. As revealed by double-staining immunoﬂuorescence, Dsg3 bound to PV-IgG is almost absent in new formed desmosomes containing Dsg1
(punctate spots) after 24 h of growth in presence of 25% PV serum (A–C). After 48 h, cellular transinteraction were lacking (D–F), although Dsg still
localized on cell borders. Figure is representative of independent experiments carried out with PV1–3 and C1–3 sera.
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IgG to Dsg3 perturbs its recruitment at sites of intercellular
contact and subsequent assembly into desmosomes.
Another major ﬁnding of our work is that the total cellular
amount of Dsg3 remains unchanged within 36 h of treatment
with PV serum. Aoyama and Kitajima have reported a dra-
matic depletion of Dsg3 in response to PV IgG and PV sera
stimulation [11], but carcinoma DJM-1 cells they used have
been shown to be much more sensitive to the PV autoantibod-
ies and the number of desmosomes much smaller than normal
keratinocytes. Thus, PV IgG-induced changes on DJM-1 were
far from simulating physiologic conditions.
Regulation of cell–cell adhesion appears to be a complex and
ﬁnely orchestrated mechanism. Although autoantibodies
against Dsg3 have been demonstrated to cause defects of inter-
cellular adhesion [24,25], it remains unclear whether an im-
paired function of Dsg3 is suﬃcient to disrupt epithelial
integrity. Indeed, the stability of intercellular junctions also re-
lies on desmocollins and E-cadherin [26,27]. In PV patients, the
ﬁnding of detectable titres of anti-ICS antibody not always
associates with clinical manifestations of pemphigus and, how-
ever, blisters appear only in some areas of the body [28,29].
Rather, PV IgG are likely to interfere with the delicate equilib-
rium underlying the maintenance of stable intercellular con-
tacts. Our study demonstrates for what we believe is the ﬁrst
time that PV serum may induce acantholytic changes by reduc-
ing Dsg3 half-life and perturbing a stable assembly of Dsg3
into desmosomes. Furthermore, our evidence suggests that
PV IgG do not cause desmosomal split, as instead has been
previously reported in a mouse model of PV [30]. However,
the PV IgG-decorated split-desmosomes described by authors
could be half-desmosomes-like clusters before their integration
into stable complexes and not the result of desmosomal disrup-
tion.
The results of this study are in agreement with a view of the
acantholysis as a well coordinate phenomenon in which a
plethora of cell signals participates. One of the key points
may be the reduction of Dsg3 half-life reported here. We fa-
vour the hypothesis that acantholysis takes place in vivo when
cells become unable to maintain steady state levels of Dsg3.
Our data also support the hypothesis that the defect of adhe-sion results from a perturbation of Dsg3 assembly into desmo-
somes. Nevertheless, it seems now clear that PV IgG can not
induce direct disruption of already formed desmosomes.
In conclusion, our experiments have provided further insight
into the mechanisms underlying epithelial blistering observed
in pemphigus vulgaris. Reduction of Dsg3 half-life together
with perturbation of its assembly into desmosomes may repre-
sent critical phenomena when cells result incapable of compen-
sating this acquired deﬁcit of adhesion and maintaining
homeostasis.References
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